Search Results - Hinke, Axel
- Showing 1 - 6 results of 6
-
1
Nivolumab switch maintenance therapy after tyrosine kinase inhibitor induction in metastatic renal cell carcinoma: a randomized clinical trial by the interdisciplinary working grou... by Grünwald, Viktor (Author) , Ivanyi, Philipp (Author) , Zschäbitz, Stefanie (Author) , Wirth, Manfred (Author) , Staib, Peter (Author) , Schostak, Martin (Author) , Dargatz, Philip (Author) , Müller, Lothar (Author) , Metz, Michael (Author) , Bergmann, Lothar (Author) , Steiner, Thomas (Author) , Welslau, Martin (Author) , Lorch, Anja (Author) , Rafiyan, Reza (Author) , Hellmis, Eva (Author) , Darr, Cristopher (Author) , Schütt, Philipp (Author) , Meiler, Johannes (Author) , Kretz, Thomas (Author) , Loidl, Wolfgang (Author) , Flörcken, Anne (Author) , Mänz, Martin (Author) , Hinke, Axel (Author) , Hartmann, Arndt (Author) , Grüllich, Carsten (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
CONKO-006: a randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer : final results by Sinn, Marianne (Author) , Liersch, Torsten (Author) , Riess, Hanno (Author) , Gellert, Klaus (Author) , Stübs, Patrick (Author) , Waldschmidt, Dirk Thomas (Author) , Lammert, Frank (Author) , Maschmeyer, Georg (Author) , Bechstein, Wolf Otto (Author) , Bitzer, Michael (Author) , Denzlinger, Claudio (Author) , Hofheinz, Ralf-Dieter (Author) , Lindig, Udo (Author) , Ghadimi, Michael (Author) , Hinke, Axel (Author) , Striefler, Jana K. (Author) , Pelzer, Uwe (Author) , Bischoff, Sven (Author) , Bahra, Marcus (Author) , Oettle, Helmut (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
3
Ten-year results of intense dose-dense chemotherapy show superior survival compared to a conventional schedule in high-risk primary breast Cancer: final results of AGO phase III id... by Möbus, Volker (Author) , Jackisch, Christian (Author) , Lueck, Hans-Joachim (Author) , Du Bois, Andreas (Author) , Thomssen, Christoph (Author) , Kuhn, Walther (Author) , Nitz, Ulrike (Author) , Schneeweiss, Andreas (Author) , Huober, Jens (Author) , Harbeck, Nadia (Author) , Minckwitz, Gunter von (Author) , Runnebaum, Ingo B. (Author) , Hinke, Axel (Author) , Konecny, Gottfried E. (Author) , Untch, Michael (Author) , Kurbacher, Christian M. (Author) , Maintz, Corinna (Author) , Morenz, Bärbel (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
4
Response: [adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial] by Möbus, Volker (Author) , Jackisch, Christian (Author) , Schneeweiss, Andreas (Author) , Huober, Jens (Author) , Lück, Hans-Joachim (Author) , Du Bois, Andreas (Author) , Thomssen, Christoph (Author) , Kurbacher, Christian M. (Author) , Kuhn, Walther (Author) , Nitz, Ulrike A. (Author) , Runnebaum, Ingo B. (Author) , Hinke, Axel (Author) , Kreienberg, Rolf (Author) , Untch, Michael (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Editorial Online Resource -
5
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer by Möbus, Volker (Author) , Jackisch, Christian (Author) , Schneeweiss, Andreas (Author) , Huober, Jens (Author) , Lück, Hans-Joachim (Author) , Du Bois, Andreas (Author) , Thomssen, Christoph (Author) , Kurbacher, Christian M. (Author) , Kuhn, Walther (Author) , Nitzschke, Ulrike Elisabeth (Author) , Runnebaum, Ingo B. (Author) , Hinke, Axel (Author) , Kreienberg, Rolf (Author) , Untch, Michael (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
6
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer
Other Authors: “…Hinke, Axel…”
Call Number: Loading…
Located: Loading…
Article (Journal)
Search Tools:
Related Subjects
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Cyclophosphamide
Disease-Free Survival
Dose-Response Relationship, Drug
Epirubicin
Female
Humans
Lymphatic Metastasis
Metastatic renal cell carcinoma
Middle Aged
Nivolumab
Paclitaxel
Risk Factors
Survival Rate
Switch maintenance therapy
Tyrosine kinase inhibitor
dose-dense
high-risk early breast cancer
intense dose-dense